Search

Author/Creator Elgeioushi, Nairouz

1. Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies. Issue 1 (22nd August 2019)

Authors:
Naing, Aung; Infante, Jeffrey; Goel, Sanjay; Burris, Howard; Black, Chelsea; Marshall, Shannon; Achour, Ikbel; Barbee, Susannah; May, Rena; Morehouse, Chris; Pollizzi, Kristen; Song, Xuyang; Steele, Keith; Elgeioushi, Nairouz; Walcott, Farzana; Karakunnel, Joyson; LoRusso, Patricia; Weise, Amy; E...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. (7th November 2013)

Authors:
Forero, Andres; Hamadani, Mehdi; Kipps, Thomas; Fanale, Michelle; Cuneo, Antonio; Perez de Oteyza, Jaime; Gladstone, Douglas; Andre, Marc; Bellam, Naresh; Goswami, Trishna; Ibrahim, Ramy; Schneider, Amy; Liang, Meina; Eck, Steven; Elgeioushi, Nairouz; Herbst, Ronald; Cheson, Bruce D
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search